BridgeMD
New treatment option for Opioid Use Disorder
Official title Injectable Buprenorphine in Prison: A Preference Trial
ClinicalTrials.gov ID: NCT06880718
What this study is testing
What is Brixadi (Injectable Buprenorphine)?
Brixadi (Injectable Buprenorphine) is an investigational medicine, given as an once-weekly injectable medicine, being studied as a potential treatment for opioid use disorder.
Also referred to as CAM2308, Buvidal.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this pilot trial is to compare two branded extended-release buprenorphine (XR-B) formulations (Sublocade vs. Brixadi) to explore how they improve treatment retention after release from prison among incarcerated individuals with opioid use disorder (OUD) who are transitioning back into the community.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- be at least 18 years of age and incarcerated in the RIDOC facility,
- be currently diagnosed with OUD and enrolled in the RIDOC MOUD program,
- have an expected release date within 120 days of study enrollment,
- have an interest in XR-B and
- be English speaking
You likely can't join if
- individuals who are pregnant or planning conception,
- diagnosed with a severe or acute medical or psychiatric disability preventing safe study participation or making follow-up unlikely,
- have a release date within 21 days of initiation, or
- have previously had an allergy to buprenorphine. Post-enrollment exclusion will include individuals if there is a change in release date beyond the...
The study team makes the final eligibility decision.
Where it's taking place
- Cranston, Rhode Island, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cranston, Rhode Island, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.